Literature DB >> 7353570

Efficiency of heparin in the treatment of newborn infants with respiratory distress syndrome and disseminated intravascular coagulation.

U Göbel, H von Voss, H Jürgens, C Petrich, R Pothmann, I Sprock, P Lemburg.   

Abstract

Forty newborns with severe shock and disseminated intravascular coagulation were randomized for treatment with heparin or placebo. Mortality was equal in both groups. The heparin group required significantly shorter periods of artificial ventilation. The coagulation system improved faster, and the coagulation pattern showed normal values in the treatment group. Due to the low number of cases, these differences could not be statistically confirmed.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7353570     DOI： 10.1007/bf00444754

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  13 in total

1.  [Results of preventive heparin therapy of intravasal coagulation in low-birth-weight newborn infants].

Authors:  B Maak; J Frenzel
Journal:  Kinderarztl Prax       Date:  1976-02

2.  Hageman factor and disseminated intravascular coagulation (DIC) in newborns and rabbits.

Authors:  J J Corrigan; E J Sell; C Pagel
Journal:  Pediatr Res       Date:  1977-08       Impact factor: 3.756

3.  Intracranial haemorrhage and clotting defects in low-birth-weight infants.

Authors:  O P Gray; A Ackerman; A J Fraser
Journal:  Lancet       Date:  1968-03-16       Impact factor: 79.321

4.  Controlled trial of fresh frozen plasma in asphyxiated low birthweight infants.

Authors:  G Hambleton; W J Appleyard
Journal:  Arch Dis Child       Date:  1973-01       Impact factor: 3.791

5.  Fetal and neonatal biochemistry and Apgar scores.

Authors:  H Modanlou; S Y Yeh; E H Hon; A Forsythe
Journal:  Am J Obstet Gynecol       Date:  1973-12-01       Impact factor: 8.661

6.  [Parietal thromboplastin time, thromboplastin time fibrinogen, thrombin time and thrombocyte count in healthy and sick newborn infants].

Authors:  U Göbel; P Riech
Journal:  Monatsschr Kinderheilkd       Date:  1972-12

7.  Hypercoagulability in premature infants with special reference to the respiratory distress syndrome and hemorrhage. II. The effect of heparin.

Authors:  M Markarian; L O Lubchenco; E Rosenblüt; F Fernandez; D Lang; J J Jackson; A E Bannon; A Lindley; J H Githens; R Martorell
Journal:  Biol Neonate       Date:  1971

8.  [Defibrination syndrome in newborn infants].

Authors:  G Weissbach; H Lenk
Journal:  Helv Paediatr Acta       Date:  1971-04

Review 9.  [Pathogenesis and therapy of shock in children (author's transl)].

Authors:  K Stehr
Journal:  Klin Padiatr       Date:  1976-11       Impact factor: 1.349

10.  Alpha1-antitrypsin and alpha2-macroglobulin in newborn infants. II. Relation to the coagulation system.

Authors:  U Göbel; A Triebel; C Petrich; H von Voss
Journal:  Eur J Pediatr       Date:  1978-09-08       Impact factor: 3.183
View more
  6 in total

Review 1.  Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.

Authors:  Arturo J Martí-Carvajal; Vidhu Anand; Ivan Solà
Journal:  Cochrane Database Syst Rev       Date:  2015-06-24

2.  Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation.

Authors:  Akira Shirahata; Jun Mimuro; Hoyu Takahashi; Isao Kitajima; Hajime Tsuji; Yutaka Eguchi; Tadashi Matsushita; Masahiro Kajiki; Goichi Honda; Yoichi Sakata
Journal:  Eur J Pediatr       Date:  2013-09-05       Impact factor: 3.183

Review 3.  The Effect of Heparin and Its Preparations on Disseminated Intravascular Coagulation Mortality and Hospitalization: A Systematic Review.

Authors:  Navid Omidkhoda; Farshad Abedi; Vahid Ghavami; Hossein Rahimi; Sara Samadi; Omid Arasteh; Amir Hooshang Mohammadpour
Journal:  Int J Clin Pract       Date:  2022-07-09       Impact factor: 3.149

4.  Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.

Authors:  R von Kries; H Stannigel; U Göbel
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

5.  Low antithrombin III in neonatal shock: DIC or non-specific protein depletion?

Authors:  B K Schmidt; T Muraji; A Zipursky
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

6.  Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.

Authors:  Hiroyuki Nagafuchi; Yutaka Eguchi; Toshiaki Ikeda
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.